Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danshen polyphenolic acid refers to a mixture of water-soluble phenolic acids extracted from the root of Salvia miltiorrhiza Bunge (Danshen), a widely used traditional Chinese medicinal herb. The main active components are salvianolic acids, especially salvianolic acid A and B, which are known for their strong antioxidant, anti-thrombotic, anti-platelet aggregation, and anti-inflammatory activities. These compounds act primarily by inhibiting lipid peroxidation and platelet aggregation. Danshen polyphenolic acids have been extensively studied for their pharmacological effects in cardiovascular diseases (such as heart failure and brain infarction), cerebrovascular diseases, metabolic disorders like diabetes, as well as potential roles in cancer therapy. They are typically administered as injections or oral preparations in China for promoting blood circulation and removing blood stasis[1][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on danshen polyphenolic acid.